Filing Details
NEOGEN CORP (NASDAQ:NEOG) filed its annual report (Form 10-K) with the Securities and Exchange Commission on July 30, 2026.
The Healthcare company's annual report covers fiscal year 2026.
Filing Details NEOGEN CORP (NASDAQ:NEOG) filed its annual report (Form 10-K) with the Securities and Exchange Commission on July 30, 2026. The Healthcare company's annual report…

NEOGEN CORP (NASDAQ:NEOG) filed its annual report (Form 10-K) with the Securities and Exchange Commission on July 30, 2026.
The Healthcare company's annual report covers fiscal year 2026.
NEOGEN CORP's stock currently trades at $11.53 with a market capitalization of $1.5B.
The 10-K is the most comprehensive annual report a public company files, containing detailed financial statements, management discussion and analysis (MD&A), risk factors, and business segment breakdowns. For NEOGEN CORP investors, the 10-K provides depth that quarterly reports don't — including full-year trends, long-term debt schedules, and off-balance-sheet items.
Key sections to review: MD&A for management's narrative on performance, risk factors for newly disclosed threats, and the notes to financial statements for accounting changes that could affect reported earnings.
All SEC filings for NEOGEN CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NEOG Stock Page
Browse all filings on our NEOG SEC filings page.
Public companies like NEOGEN CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · NEOG
$11.95
Up: +$0.12 · +1.01%
Live quote updated
Keep reading